Charles Schwab’s Pulmatrix PULM Stock Holding History

Charles Schwab’s Portfolio PULM Stock Details PULM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,479	Closed	-$40K	–	3514
2021 Q1	$40K	Buy	+1,479	New	+$45.3K	﹤0.01%	3463

Other funds holding PULM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Charles Schwab's PULM Position: Q2 2021 in Review

Charles Schwab sold out of Pulmatrix (PULM) in Q2 2021, closing a stake of 1,479 shares — an estimated $40K sold.

Charles Schwab first reported a position in PULM in Q1 2021 and held it in 1 quarter. The position peaked at $40K in Q1 2021. 22 funds tracked by Wall St. Rank hold PULM as of Q2 2021.

Charles Schwab reported no remaining Pulmatrix position as of Q2 2021 after selling out during the quarter.
Charles Schwab sold 1,479 Pulmatrix shares in Q2 2021, an estimated $40K.
Charles Schwab first reported a position in Pulmatrix in Q1 2021 and held it in 1 quarter.
Charles Schwab's Pulmatrix position peaked at $40K in Q1 2021.
22 funds tracked by Wall St. Rank held Pulmatrix as of Q2 2021.

Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.